Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.

Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder caused by mutations in the dystrophin gene that result in the absence of functional protein. Antisense-mediated exon-skipping is one of the most promising approaches for the treatment of DMD because of its capacity to correct the r...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Goyenvalle, A, Babbs, A, Powell, D, Kole, R, Fletcher, S, Wilton, S, Davies, K
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2010

Míreanna comhchosúla

Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping
de réir: Goyenvalle, A, et al.
Foilsithe / Cruthaithe: (2010)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
de réir: Goyenvalle, A, et al.
Foilsithe / Cruthaithe: (2012)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
de réir: Goyenvalle, A, et al.
Foilsithe / Cruthaithe: (2012)

Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs.
de réir: Yokota, T, et al.
Foilsithe / Cruthaithe: (2012)

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
de réir: Lu, Q, et al.
Foilsithe / Cruthaithe: (2003)

Use of antisense-mediated exon skipping to generate dystrophin in muscles of the mdx dystrophic mouse
de réir: Lu, Q, et al.
Foilsithe / Cruthaithe: (2004)

Upgrading U7snRNA To Complete Efficient Rescue of Dystrophin by Exon-Skipping in DMD Patients
de réir: Goyenvalle, A, et al.
Foilsithe / Cruthaithe: (2009)

Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
de réir: Wakefield, P, et al.
Foilsithe / Cruthaithe: (2000)

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: An open-label, phase 2, dose-escalation study
de réir: Cirak, S, et al.
Foilsithe / Cruthaithe: (2011)

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.
de réir: Cirak, S, et al.
Foilsithe / Cruthaithe: (2011)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
de réir: Kane L Greer, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Context dependent effects of chimeric peptide morpholino conjugates contribute to dystrophin exon-skipping efficiency
de réir: Yin, HF, et al.
Foilsithe / Cruthaithe: (2016)

Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency
de réir: HaiFang Yin, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin Gene
de réir: Sue Fletcher, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice
de réir: Daniel J. Ham, et al.
Foilsithe / Cruthaithe: (2019-09-01)

In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.
de réir: Aoki, Y, et al.
Foilsithe / Cruthaithe: (2010)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
de réir: Guiraud, S, et al.
Foilsithe / Cruthaithe: (2019)

Effective exon skipping and dystrophin restoration by 2'-o-methoxyethyl antisense oligonucleotide in dystrophin-deficient mice.
de réir: Lu Yang, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
de réir: Kennedy, T, et al.
Foilsithe / Cruthaithe: (2017)

Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
de réir: Zhi Yon Charles Toh, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
de réir: Tahnee L. Kennedy, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
de réir: Gang Han, et al.
Foilsithe / Cruthaithe: (2016-03-01)

Functional substitution by TAT-utrophin in dystrophin-deficient mice.
de réir: Kevin J Sonnemann, et al.
Foilsithe / Cruthaithe: (2009-05-01)

MOTS‐c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice
de réir: Ning Ran, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity
de réir: Justin P. Hardee, et al.
Foilsithe / Cruthaithe: (2021-03-01)

AAV-U7snRNA mediated multi exon-skipping for Duchenne muscular dystrophy
de réir: Goyenvalle, A, et al.
Foilsithe / Cruthaithe: (2010)

A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
de réir: Yin, H, et al.
Foilsithe / Cruthaithe: (2009)

AAV-U7snRNA mediated multi exon-skipping for Duchenne muscular dystrophy
de réir: Goyenvalle, A, et al.
Foilsithe / Cruthaithe: (2011)

Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.
de réir: Baban, D, et al.
Foilsithe / Cruthaithe: (2008)

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
de réir: Hanson, B, et al.
Foilsithe / Cruthaithe: (2022)

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
de réir: Britt Hanson, et al.
Foilsithe / Cruthaithe: (2022-12-01)

The utrophin and dystrophin genes share similarities in genomic structure.
de réir: Pearce, M, et al.
Foilsithe / Cruthaithe: (1993)

AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy
de réir: Le Hir, M, et al.
Foilsithe / Cruthaithe: (2013)

Electroporation Enhanced Effect of Dystrophin Splice Switching PNA Oligomers in Normal and Dystrophic Muscle
de réir: Camilla Brolin, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Immunogold confirmation that utrophin is localized to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle.
de réir: Culle, M, et al.
Foilsithe / Cruthaithe: (2001)

Link between MHC Fiber Type and Restoration of Dystrophin Expression and Key Components of the DAPC by Tricyclo-DNA-Mediated Exon Skipping
de réir: Saleh Omairi, et al.
Foilsithe / Cruthaithe: (2017-12-01)

Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD
de réir: Ugur Akpulat, et al.
Foilsithe / Cruthaithe: (2018-12-01)

Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
de réir: Annemieke Aartsma-Rus
Foilsithe / Cruthaithe: (2022-12-01)

Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy.
de réir: Goyenvalle, A, et al.
Foilsithe / Cruthaithe: (2009)

Confirmation by immunogold labeling that utrophin is localised to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle
de réir: Cullen, M, et al.
Foilsithe / Cruthaithe: (2001)